IDEXX Laboratories (LTS:0J8P) Short-Term Debt: $669 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0J8P IDEXX Laboratories Inc LTS:0J8P
97 GF Score
Price $591.05
GF Value $635.92
Valuation Fairly Valued
View Full Analysis

What is IDEXX Laboratories Short-Term Debt?

IDEXX Laboratories LTS:0J8P -1.42% 97 Short-Term Debt is $669 Mil as of Jun. 2026. GuruFocus rates LTS:0J8P with a GF Score™ of 97/100 and a GF Value™ of $635.92 (Fairly Valued).

IDEXX Laboratories's Short-Term Debt for the quarter that ended in Jun. 2026 was $669 Mil.

IDEXX Laboratories's quarterly Short-Term Debt increased from Dec. 2025 ($473 Mil) to Mar. 2026 ($680 Mil) but then declined from Mar. 2026 ($680 Mil) to Jun. 2026 ($669 Mil).

IDEXX Laboratories's annual Short-Term Debt increased from Dec. 2023 ($325 Mil) to Dec. 2024 ($418 Mil) and increased from Dec. 2024 ($418 Mil) to Dec. 2025 ($473 Mil).

IDEXX Laboratories Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

IDEXX Laboratories Short-Term Debt Related Terms

IDEXX Laboratories Short-Term Debt Historical Data

* Premium members only.

The historical data trend for IDEXX Laboratories's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDEXX Laboratories Short-Term Debt Chart

IDEXX Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 148.50 653.98 325.00 417.79 473.00

IDEXX Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 653.99 605.00 473.00 680.00 669.00
LTS:0J8P
97GF Score
IDEXX Laboratories Inc LTS:0J8P
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $669 Mil mean?
IDEXX Laboratories (LTS:0J8P) has a Short-Term Debt of $669 Mil as of Jun. 2026.
Is IDEXX Laboratories' Short-Term Debt too high?
IDEXX Laboratories' current Short-Term Debt is $669 Mil. Overall, IDEXX Laboratories has a GF Score™ of 97/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does IDEXX Laboratories' Short-Term Debt compare to A and NTRA?
IDEXX Laboratories' Short-Term Debt of $669 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Diagnostics & Research company?
A good Short-Term Debt depends on the Medical Diagnostics & Research industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. IDEXX Laboratories's current Short-Term Debt is $669 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEXX Laboratories stock overvalued right now?
Based on GuruFocus' analysis, IDEXX Laboratories (LTS:0J8P) is currently considered Fairly Valued. The stock's GF Value™ is $635.92, compared to a current price of $591.05 — trading 7.1% below its estimated fair value. The current Short-Term Debt is $669 Mil. IDEXX Laboratories' overall GF Score™ is 97/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For IDEXX Laboratories (LTS:0J8P), the current Short-Term Debt is $669 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IDEXX Laboratories (LTS:0J8P) Overvalued in 2026?

Based on GuruFocus' analysis, IDEXX Laboratories stock appears to be undervalued. The current stock price of $591.05 is trading 7.1% below its estimated GF Value™ of $635.92. GuruFocus considers IDEXX Laboratories to be Fairly Valued.

Key valuation signals for LTS:0J8P:

  • Short-Term Debt: $669 Mil
  • GF Value™: $635.92 vs. price of $591.05 (7.1% below fair value)
  • GF Score™: 97/100

No single metric tells the full story. See the LTS:0J8P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IDEXX Laboratories Business Description

Address One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
97GF Score

Get the complete analysis for LTS:0J8P

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$591.05
Price
$635.92
GF Value